COVID, Collaboration and the Cambridge Cluster: 2020 AstraZeneca Exchange

The event will be a unique opportunity to hear from AstraZeneca CEO Pascal Soriot, EVP of Biopharmaceutical R&D Sir Mene Pangalos, plus key figures from the University of Cambridge and the University of Oxford on the collaborative efforts taken to tackle COVID-19 and the science-led approaches to developing testing and treatment for the disease. The event will showcase the critical role partnership has played in orchestrating the UK and global response to the pandemic, and attendees will hear first-hand from key leaders directly involved.

Dates Wednesday, November 25, 2020 - Download as vCalendar
Event Times: 14:15 to 18:00
Venue Online
Website Event website

Event details:

The Agenda is:

14:15 Attendees to join

14:25 Welcome – Shaun Grady, SVP Business Development Operations, AstraZeneca

14:30 Keynote and Q&A: Collaboration to combat COVID-19: Politicians and Partnerships –Pascal Soriot, CEO, AstraZeneca

15:00 Panel Discussion: Creating the Cambridge COVID-19 Test Centre: lessons in collaboration and for the future

  • Professor Andy Neely, Pro-Vice-Chancellor for Enterprise and Business Relations, University of Cambridge
  • Rebecca Scott, Chief of Staff, Medicinal Science and Technology
  • GSK Ian Waddell, Executive Director, Charles River Laboratories
  • Clive Green, Executive Director, Sample Management Discovery Sciences, AstraZeneca
  • Penny James, COO R&D BioPharmaceuticals, AstraZeneca
  • Moderator: Steve Rees, VP Discovery Biology, AstraZeneca 

15:30 Panel Discussion: Perspectives on partnering in the pandemic 

  • Professor Sarah Gilbert, Professor of Vaccinology, Jenner Institute & Nuffield Department of Clinical Medicine
  • Professor Andy Pollard, Director of the Oxford Vaccine Group
  • Per Alfredsson, SVP Biologics Operations, AstraZeneca
  • Sjoerd Hubben, VP Global Government Affairs & Policy, AstraZeneca
  • Tonya Villafana, Global Franchise Head - Infection, AstraZeneca
  • Moderator: Kumar Srinivasan, VP Global Head of Business Development and Licensing, AstraZeneca

16:00 Keynote: Turning science into medicine: pivoting during the pandemic – Sir Mene Pangalos, EVP and President BioPharmaceuticals R&D, AstraZeneca

16:30 AZ with Accelerate @ Babraham – Start-up Pitching Competition

Facilitator: Hitesh Sanganee, Head of Emerging Innovations, AstraZeneca

17:00 Reflections on the day, opening the voting for winning pitch and winner announcement –Shaun Grady, SVP Business Development Operations, AstraZeneca

17:15 Virtual networking 

18:00 Adjourn

Please register to attend here.



AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases.